Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 34451-34500 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05886868
Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors
PHASE1Recruiting
66 participants
Started: Oct 24, 2023 · Completed: Feb 28, 2025
1 condition1 sponsor4 locations
NCT06077877
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors
PHASE1/PHASE2Recruiting
135 participants
Started: Oct 24, 2023 · Completed: Jun 29, 2027
1 condition1 sponsor9 locations
NCT05790668
Motivational Refinements for Facilitating Reinforcement Schedule Thinning
NARecruiting
30 participants
Started: Oct 24, 2023 · Completed: Aug 31, 2028
2 conditions1 sponsor2 locations
NCT06088199
A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
PHASE3Recruiting
50 participants
Started: Oct 24, 2023 · Completed: Jul 6, 2026
1 condition1 sponsor30 locations
NCT06092671
Effect of FPCA on Incidence of Emergency Delirium in Children After Surgery
NARecruiting
444 participants
Started: Oct 24, 2023 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT06062550
Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery
PHASE4Recruiting
312 participants
Started: Oct 24, 2023 · Completed: Oct 31, 2025
5 conditions1 sponsor1 location
NCT05759728
A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer
PHASE1/PHASE2Recruiting
45 participants
Started: Oct 24, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05725265
LLLT for BCRL: a Randomized, Placebo-controlled Study
NARecruiting
54 participants
Started: Oct 24, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06106516
Vital Sign Monitor Device Validation - WARD
N/ARecruiting
1,000 participants
Started: Oct 24, 2023 · Completed: Dec 31, 2028
2 conditions2 sponsors2 locations
NCT06041659
Functional Magnetic Resonance-Based Observations of Brain Networks in Moyamoya Disease Patients Under Anesthesia
N/ARecruiting
48 participants
Started: Oct 24, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06081179
Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans
PHASE1Recruiting
120 participants
Started: Oct 24, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05849207
Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
PHASE1Recruiting
26 participants
Started: Oct 24, 2023 · Completed: Jul 1, 2028
1 condition1 sponsor1 location
NCT05945732
DESTINY Breast Respond HER2-low Europe
N/ARecruiting
1,350 participants
Started: Oct 24, 2023 · Completed: Sep 1, 2028
3 conditions1 sponsor198 locations
NCT05984277
A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.
PHASE3Recruiting
1,200 participants
Started: Oct 24, 2023 · Completed: Mar 23, 2029
1 condition1 sponsor302 locations
NCT06158945
The Role of Endothelin 1 as a Marker of Renal Impairment in Sickle Cell Disease
N/ARecruiting
30 participants
Started: Oct 24, 2023 · Completed: Oct 23, 2024
1 condition1 sponsor1 location
NCT07034053
Clofarabine Therapy in Locally Advanced or Metastatic Urothelial Carcinoma
PHASE1/PHASE2Recruiting
50 participants
Started: Oct 24, 2023 · Completed: Nov 30, 2028
2 conditions1 sponsor1 location
NCT06166810
Capture of Healthy Gut Bacteria Associated to High Fiber Diet
N/ARecruiting
10 participants
Started: Oct 24, 2023 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT06734247
Arterial Stiffness for Improved Prediction of Coronary Artery Disease by Coronary CT Angiography
N/ARecruiting
200 participants
Started: Oct 24, 2023 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT06156410
Cabozantinib With Ifosfamide in Ewing's Sarcoma and Osteosarcoma
PHASE1Recruiting
30 participants
Started: Oct 24, 2023 · Completed: Nov 30, 2028
2 conditions4 sponsors4 locations
NCT06106594
VOLT CE Mark Study
NARecruiting
300 participants
Started: Oct 24, 2023 · Completed: Dec 31, 2026
4 conditions1 sponsor16 locations
NCT05968768
To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
PHASE2Recruiting
24 participants
Started: Oct 24, 2023 · Completed: Jul 31, 2028
1 condition2 sponsors2 locations
NCT05946564
A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial
PHASE3Recruiting
126 participants
Started: Oct 24, 2023 · Completed: Oct 24, 2027
3 conditions2 sponsors24 locations
NCT06135311
Optimal Pulse Width Used in Transcutaneous Electrical Nerve Stimulation for Treating Nocturnal Enuresis in Children
NARecruiting
70 participants
Started: Oct 24, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06214975
EXOPULSE Mollii Suit, Motor Function & Stroke (EXOSTROKE 2)
NARecruiting
36 participants
Started: Oct 24, 2023 · Completed: Dec 2, 2024
3 conditions1 sponsor1 location
NCT06720766
Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With Obesity
N/ARecruiting
600 participants
Started: Oct 24, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT06257433
InformationSeekingMesolimbicEngagementStudy2
NARecruiting
80 participants
Started: Oct 24, 2023 · Completed: Aug 1, 2026
1 condition1 sponsor1 location
NCT05726708
Impact of an E-Learning Coaching for Parents of Young Children With Autism
NARecruiting
99 participants
Started: Oct 24, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06062524
Guo's False Lumen Embolization : The First in Man Study of WeFlow-EndoSeal Aorta Vascular Plug System
NARecruiting
20 participants
Started: Oct 24, 2023 · Completed: May 31, 2026
1 condition1 sponsor3 locations
NCT06066424
Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)
PHASE1Recruiting
54 participants
Started: Oct 24, 2023 · Completed: Apr 30, 2040
1 condition2 sponsors1 location
NCT05795478
Effects of Oxycodone Combined With Pregabalin on Chronic Postsurgical Pain in Spinal Surgery
NARecruiting
264 participants
Started: Oct 24, 2023 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT06092866
Digital Versus Telephone Symptom Assessment and Triage in Primary Care
NARecruiting
120 participants
Started: Oct 24, 2023 · Completed: Dec 31, 2024
5 conditions1 sponsor1 location
NCT05949684
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
PHASE3Recruiting
360 participants
Started: Oct 24, 2023 · Completed: Mar 11, 2030
1 condition1 sponsor169 locations
NCT06056505
Virtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy
NARecruiting
370 participants
Started: Oct 24, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor8 locations
NCT05775718
Shingrix In Recipients of Allogeneic Transplants
PHASE2Recruiting
55 participants
Started: Oct 24, 2023 · Completed: Dec 1, 2030
2 conditions2 sponsors1 location
NCT06270537
Post-market Clinical Trial of the Dominus® Stent-Graft
N/ARecruiting
100 participants
Started: Oct 24, 2023 · Completed: Feb 28, 2029
1 condition1 sponsor3 locations
NCT05911620
Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous Hypercorticism
NARecruiting
21 participants
Started: Oct 24, 2023 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT06193421
High-Dose Ambroxol in GBA1-Related Parkinson
PHASE1/PHASE2Recruiting
40 participants
Started: Oct 24, 2023 · Completed: Apr 30, 2025
2 conditions1 sponsor1 location
NCT06110923
A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846
PHASE1Recruiting
40 participants
Started: Oct 24, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06096974
Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS
PHASE1Recruiting
60 participants
Started: Oct 24, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor3 locations
NCT06108375
Differences in Acceptability of Music Therapy Sessions Played Live Compared to a Recording Thereof
NARecruiting
25 participants
Started: Oct 24, 2023 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT05824442
Evaluation of a New Multiplex Quantitative PCR Technique for the Diagnosis of Echinococcosis
NARecruiting
43 participants
Started: Oct 24, 2023 · Completed: Oct 31, 2026
2 conditions1 sponsor1 location
NCT06090266
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
PHASE1/PHASE2Recruiting
168 participants
Started: Oct 24, 2023 · Completed: Feb 1, 2027
7 conditions1 sponsor4 locations
NCT06366256
Simplified Ultrasound Feedback for Speech Remediation
NARecruiting
24 participants
Started: Oct 24, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05645523
Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
EARLY_PHASE1Recruiting
25 participants
Started: Oct 24, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor3 locations
NCT05233956
Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya
NARecruiting
600 participants
Started: Oct 23, 2023 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT06105892
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
NARecruiting
100 participants
Started: Oct 23, 2023 · Completed: Mar 20, 2027
3 conditions5 sponsors1 location
NCT06213246
Sleep and Performance in Surgeons
NARecruiting
23 participants
Started: Oct 23, 2023 · Completed: Dec 23, 2024
1 condition1 sponsor1 location
NCT06013111
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors
PHASE1Recruiting
9 participants
Started: Oct 23, 2023 · Completed: Sep 1, 2026
1 condition2 sponsors1 location
NCT05954494
Protection Response to Cellular Stress in BPAN's Patient Study
N/ARecruiting
30 participants
Started: Oct 23, 2023 · Completed: Oct 23, 2025
1 condition1 sponsor2 locations
NCT05886764
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
NARecruiting
180 participants
Started: Oct 23, 2023 · Completed: Jul 31, 2027
3 conditions2 sponsors1 location